Ostcopontin gene polymorphism as marker predicting the efficacy of interferon-based therapics in patients with chronic hepatitis C / Rehab Mustafa Abdelfadel ; Supervised Olfat Gamil Shaker , Amr Aly Zahra , Salwa Fayez Hasan
Material type:
- التحور فى جين الاستيوبونتين كدلالة لتوقع كفائه العلاج بالانترفيرون فى مرضى الالتهاب الكبدى المزمن سى [Added title page title]
- Issued also as CD
Item type | Current library | Home library | Call number | Copy number | Status | Barcode | |
---|---|---|---|---|---|---|---|
![]() |
قاعة الرسائل الجامعية - الدور الاول | المكتبة المركزبة الجديدة - جامعة القاهرة | Cai01.11.03.M.Sc.2011.Re.O (Browse shelf(Opens below)) | Not for loan | 01010110056569000 | ||
![]() |
مخـــزن الرســائل الجـــامعية - البدروم | المكتبة المركزبة الجديدة - جامعة القاهرة | Cai01.11.03.M.Sc.2011.Re.O (Browse shelf(Opens below)) | 56569.CD | Not for loan | 01020110056569000 |
Thesis (M.Sc.) - Cairo University - Faculty of Medicine - Department of Medical Biochemistry
Viral hepatitis is T cell-mediated and ostcopontin induce T cell chemotaxis, support adhesion, proliferation, and also enhance expression of T helper 1 (Th1) cytokines. Genetic polymorphisms in the ostcopontin gene (OPN) determine the magnitude of immunity against rickettsial infection in mice. Similar polymorphisms, if present also in human beings, might affect hepatitis activity and the response to treatment by interferon and ribavirin in those infected with HCV
Issued also as CD
There are no comments on this title.